Loading company…
Mariposa Therapeutics develops treatments for keratin-related skin disorders such as Epidermolysis Bullosa Simplex and psoriasis.
Mariposa Therapeutics Limited develops treatments for keratin-related disorders, including Epidermolysis Bullosa Simplex and psoriasis. Founded in 2019 and based in Cardiff, UK, it raised GBP 750,000 in SEED funding in March 2026, led by the Development Bank of Wales, with DEBRA Research GmbH and company management participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in